bibliographic entry 11912350 [be/11912350]
https://w3id.org/oc/corpus/be/11912350

is a
content
  • Lambrechts, D, Claes, B, Delmar, P. VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials, Lancet Oncol, 2012, 13, 7, 724, 733, PMID: 22608783
references